State Street’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-894,207
| Closed | -$125M | – | 3785 |
|
|
2018
Q4 | $125M | Sell |
894,207
-40,037
| -4% | -$5.61M | 0.01% | 794 |
|
|
2018
Q3 | $160M | Buy |
934,244
+57,078
| +7% | +$9.75M | 0.01% | 801 |
|
|
2018
Q2 | $152M | Sell |
877,166
-138,567
| -14% | -$24M | 0.01% | 802 |
|
|
2018
Q1 | $117M | Sell |
1,015,733
-163,589
| -14% | -$18.9M | 0.01% | 920 |
|
|
2017
Q4 | $99.3M | Buy |
1,179,322
+220,190
| +23% | +$18.5M | 0.01% | 1014 |
|
|
2017
Q3 | $88.4M | Buy |
959,132
+419,577
| +78% | +$38.7M | 0.01% | 1042 |
|
|
2017
Q2 | $43.3M | Sell |
539,555
-7,462
| -1% | -$598K | ﹤0.01% | 1449 |
|
|
2017
Q1 | $23M | Buy |
547,017
+332,696
| +155% | +$14M | ﹤0.01% | 1831 |
|
|
2016
Q4 | $6.88M | Buy |
214,321
+4,360
| +2% | +$140K | ﹤0.01% | 2508 |
|
|
2016
Q3 | $5.5M | Buy |
209,961
+8,940
| +4% | +$234K | ﹤0.01% | 2510 |
|
|
2016
Q2 | $4.66M | Buy |
201,021
+67,947
| +51% | +$1.57M | ﹤0.01% | 2627 |
|
|
2016
Q1 | $3.64M | Buy |
133,074
+9,142
| +7% | +$250K | ﹤0.01% | 2717 |
|
|
2015
Q4 | $3.53M | Buy |
123,932
+71,427
| +136% | +$2.03M | ﹤0.01% | 2726 |
|
|
2015
Q3 | $916K | Buy |
52,505
+3,505
| +7% | +$61.1K | ﹤0.01% | 3223 |
|
|
2015
Q2 | $884K | Buy |
49,000
+14,100
| +40% | +$254K | ﹤0.01% | 3266 |
|
|
2015
Q1 | $433K | Buy |
34,900
+1,100
| +3% | +$13.6K | ﹤0.01% | 3391 |
|
|
2014
Q4 | $395K | Buy |
33,800
+16,700
| +98% | +$195K | ﹤0.01% | 3430 |
|
|
2014
Q3 | $226K | Buy |
+17,100
| New | +$226K | ﹤0.01% | 3467 |
|